PMID- 21851000
OWN - NLM
STAT- MEDLINE
DCOM- 20110914
LR  - 20190816
IS  - 0869-2084 (Print)
IS  - 0869-2084 (Linking)
IP  - 6
DP  - 2011 Jun
TI  - [Role of vascular endothelial growth factor and monocyte chemoattractant 
      protein-1 in the development of endothelial dysfunction in types 1 and 2 diabetes 
      mellitus complicated by diabetic retinopathy].
PG  - 8-10
AB  - The paper presents the results of a study of the serum levels of monocyte 
      chemoattractant protein-1 (MCP-1) and vascular endothelial growth factor (VEGF) 
      in 120 patients with types 1 and 2 diabetes mellitus complicated by diabetic 
      retinopathy. All the patients with diabetes have been ascertained to show a rise 
      in the levels of MCP-1 and VEGF. Calculation of VEGF/MCP-1 ratio is proposed to 
      evaluate vascular bed lesion in diabetic patients.
FAU - Nikitina, V V
AU  - Nikitina VV
FAU - Zakharova, N B
AU  - Zakharova NB
FAU - Kamenskikh, T G
AU  - Kamenskikh TG
LA  - rus
PT  - English Abstract
PT  - Journal Article
PL  - Russia (Federation)
TA  - Klin Lab Diagn
JT  - Klinicheskaia laboratornaia diagnostika
JID - 9432021
RN  - 0 (CCL2 protein, human)
RN  - 0 (Chemokine CCL2)
RN  - 0 (Vascular Endothelial Growth Factor A)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Chemokine CCL2/*blood
MH  - Diabetes Mellitus, Type 1/*complications
MH  - Diabetes Mellitus, Type 2/*complications
MH  - Diabetic Retinopathy/*blood/etiology
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Vascular Endothelial Growth Factor A/*blood
EDAT- 2011/08/20 06:00
MHDA- 2011/09/15 06:00
CRDT- 2011/08/20 06:00
PHST- 2011/08/20 06:00 [entrez]
PHST- 2011/08/20 06:00 [pubmed]
PHST- 2011/09/15 06:00 [medline]
PST - ppublish
SO  - Klin Lab Diagn. 2011 Jun;(6):8-10.